DIABETES DRUGS MAY BOOST BRAIN HEALTH BUT EXPERTS WARN OF RISKS
By Dr. Chinta Sidharthan
Can a diabetes medication improve memory, reduce addiction, and influence mood? Scientists uncover surprising effects of GLP-1 drugs on brain health—but are there hidden risks?
Study: An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders. Image Credit: melitas / Shutterstock
In a recent study published in the journal Nature Mental Health, researchers from the United Kingdom and Canada explored how glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for diabetes and obesity, might influence cognitive and mental health disorders. They reviewed evidence suggesting that these medications could offer unexpected benefits for conditions such as dementia, depression, and addiction.
Metabolic and Cognitive Health
Scientists are increasingly recognizing that the body and mind are closely connected, especially in conditions like diabetes and obesity. People living with these metabolic diseases often face higher risks of cognitive decline, dementia, and mental health issues such as depression.
2025-02-17T04:41:21Z